封面
市場調查報告書
商品編碼
1454726

毛細血管採血設備市場-依產品類型(微容器管、微血細胞比容管、加溫裝置、採血裝置)、應用(血糖監測、血球比容、膽固醇測試)、材料、最終用途-全球預測,2024 -2032年

Capillary Blood Collection Devices Market - By Product Type (Micro-container Tube, Micro-hematocrit Tube, Warming Device, Lancing Device), Application (Glucose Monitoring, Hematocrit, Cholesterol Testing), Material, End-use-Global Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 186 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在慢性病盛行率上升、對即時檢測 (POCT) 的日益重視以及家庭醫療保健擴張的推動下,毛細血管採血設備市場預計在 2024 年至 2032 年期間將以 7.7% 的速度成長。

糖尿病、心血管疾病和癌症等慢性病的發生率穩定上升,需要頻繁的監測和診斷測試。據世界衛生組織稱,非傳染性疾病(NCD)每年奪走 4,100 萬人的生命,佔全球死亡人數的 74%。其中,1700萬人過早死亡,其中86%集中在低收入和中等收入國家。毛細血管採血設備使醫療保健提供者能夠快速有效地收集血液樣本,特別是在即時檢測 (POCT) 環境和家庭醫療保健環境中,從而促進診斷。隨著人口老化的成長和預防性醫療保健計劃的普及,對這些用於診斷測試和監測目的的設備的需求預計將增加,從而推動市場擴張。

毛細血管採血設備市場根據產品類型、應用、材料、最終用途和地區進行分類。

預計到 2032 年,加溫設備領域的需求將激增,因為它們透過溫和地加熱目標區域來促進毛細血管血液樣本的採集,從而增加血流量並最大限度地減少患者的不適。這些設備在寒冷環境中或在處理兒科或老年患者時非常有用,因為在這些情況下獲取足夠的血液樣本可能具有挑戰性。此外,加溫裝置有助於維持所採集樣本的質量,降低凝血風險並確保準確的測試結果。

玻璃材料領域預計在 2032 年獲得牽引力。玻璃具有卓越的透明度,能夠對血液樣本進行精確的目視檢查並促進準確的分析。此外,玻璃管具有化學惰性,可防止與管材相互作用,從而確保所收集樣品的完整性。這使得玻璃成為毛細血管採血裝置的首選材料,特別是在樣本品質至關重要的實驗室環境中。

在醫療基礎設施快速擴張以及慢性病盛行率上升的推動下,亞太地區毛細血管採血設備產業佔有率將在 2024 年至 2032 年期間擴大。中國、印度和日本等國家對醫療保健的投資不斷增加,刺激了對毛細血管採血設備的需求。此外,人們對預防性醫療保健措施的認知不斷增強,以及現場檢測的日益普及,也有助於該地區的市場擴張。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 慢性病盛行率增加
      • 越來越重視即時偵測 (POCT)
      • 技術進步與產品創新
      • 家庭醫療保健和自我監測的興起
    • 產業陷阱與挑戰
      • 用於測試的血量有限
      • 關於疼痛和不適的擔憂
  • 成長潛力分析
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品類型,2018 年 - 2032 年

  • 主要趨勢
  • 微型容器管
  • 微量血球容積比管
  • 加溫裝置
  • 採血裝置
    • 可調式採血裝置
    • 不可調節採血裝置
  • 其他產品類型

第 6 章:市場估計與預測:按材料分類,2018 - 2032 年

  • 主要趨勢
  • 塑膠
  • 玻璃
  • 其他材料

第 7 章:市場估計與預測:按應用,2018 - 2032

  • 主要趨勢
  • 血糖監測
  • 血球容積比測試
  • 膽固醇測試
  • 凝血測試
  • 其他應用

第 8 章:市場估計與預測:按最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 血庫
  • 診斷中心
  • 家庭診斷
  • 其他最終用戶

第 9 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Cardinal Health
  • Greiner Bio-One International GmbH
  • Medtronic plc
  • Radiometer Medical ApS
  • Roche Diagnostics
  • Sarstedt AG & Co.
  • Siemens Healthineers
  • Terumo Corporation
簡介目錄
Product Code: 8035

Capillary Blood Collection Devices Market is expected to grow at a rate of 7.7% during 2024-2032, driven by rising prevalence of chronic diseases, growing emphasis on point-of-care testing (POCT), and expansion of home healthcare.

The steady rise in chronic conditions such as diabetes, cardiovascular diseases, and cancer necessitates frequent monitoring and diagnostic testing. According to WHO, each year, noncommunicable diseases (NCDs) claim 41 million lives, accounting for 74% of all global deaths. Of these, 17 million occur prematurely, with 86% of these early deaths concentrated in low- and middle-income countries. Capillary blood collection devices facilitate diagnosis by enabling healthcare providers to collect blood samples quickly and efficiently, particularly in point-of-care testing (POCT) settings and home healthcare environments. As the aging population grows and preventive healthcare initiatives gain traction, the demand for these devices for diagnostic testing and monitoring purposes is expected to increase, driving market expansion.

Capillary Blood Collection Devices Market is classified based on product type, application, material, end-use, and region.

Warming device segment is expected to witness a demand surge by 2032, as they facilitate the collection of capillary blood samples by gently heating the targeted area, thereby increasing blood flow and minimizing discomfort for patients. These devices are beneficial in cold environments or when dealing with pediatric or elderly patients, where obtaining a sufficient blood sample can be challenging. Additionally, warming devices help preserve the quality of the collected sample, reducing the risk of clotting and ensuring accurate test results.

Glass material segment is poised to gain traction through 2032. Glass offers superior clarity, enabling precise visual inspection of blood samples and facilitating accurate analysis. Moreover, glass tubes are chemically inert, ensuring the integrity of the collected sample by preventing interactions with the tube material. This makes glass a preferred material for capillary blood collection devices, particularly in laboratory settings where sample quality is paramount.

Asia Pacific capillary blood collection devices industry share will enlarge over 2024 to 2032, driven by rapidly expanding healthcare infrastructure, coupled with the rising prevalence of chronic diseases. Countries such as China, India, and Japan are witnessing increased investments in healthcare, fueling the demand for capillary blood collection devices. Moreover, the growing awareness about preventive healthcare measures and the rising adoption of point-of-care testing contribute to market expansion in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Growing emphasis on point-of-care testing (POCT)
      • 3.2.1.3 Technological advancements and product innovations
      • 3.2.1.4 Rise in home healthcare and self-monitoring
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Limited blood volume for testing
      • 3.2.2.2 Concerns regarding pain and discomfort
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Porter's analysis
    • 3.5.1 Supplier power
    • 3.5.2 Buyer power
    • 3.5.3 Threat of new entrants
    • 3.5.4 Threat of substitutes
    • 3.5.5 Industry rivalry
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Micro-container tubes
  • 5.3 Micro-hematocrit tubes
  • 5.4 Warming devices
  • 5.5 Lancing devices
    • 5.5.1 Adjustable lancing devices
    • 5.5.2 Non-adjustable lancing devices
  • 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Material, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Plastic
  • 6.3 Glass
  • 6.4 Other materials

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Glucose monitoring
  • 7.3 Hematocrit testing
  • 7.4 Cholesterol testing
  • 7.5 Coagulation testing
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Blood banks
  • 8.4 Diagnostic centers
  • 8.5 Home diagnosis
  • 8.6 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Abbott Laboratories
  • 10.2 Becton, Dickinson and Company
  • 10.3 Cardinal Health
  • 10.4 Greiner Bio-One International GmbH
  • 10.5 Medtronic plc
  • 10.6 Radiometer Medical ApS
  • 10.7 Roche Diagnostics
  • 10.8 Sarstedt AG & Co.
  • 10.9 Siemens Healthineers
  • 10.10 Terumo Corporation